CCL2 and acute respiratory distress syndrome: As an example, BALF-EVs increase interleukins IL-1β and IL-6, Tumor Necrosis Factor α (TNFα), and CC motif chemokine Ligand 2 (CCL2) in sarcoidosis disease [22,23] and acute respiratory distress syndrome (ARDS) [24].